510(k) K896433
K896433 is an FDA 510(k) premarket notification submitted by Biokit USA, Inc. for the device "MODIFIED RUBAGEN". The FDA issued a decision of Substantially Equivalent on Nov 29, 1989. The device falls under product code LQN (Latex Agglutination Assay, Rubella), a Class II device regulated under 21 CFR 866.3510. Biokit USA, Inc. has 15 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Nov 29, 1989
- Date Received
- Nov 9, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Latex Agglutination Assay, Rubella
- Device Class
- Class II
- Regulation Number
- 866.3510
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Biokit USA, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.